Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers.
Journal: Science translational medicine
Published: June 04, 2025
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.
Journal: Cancer cell
Published: November 12, 2024
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.
Journal: Cancer cell
Published: November 09, 2023
Showing 1-3 of 3
Last Updated: 09/26/2026